Reuters logo
BRIEF-Emergent BioSolutions signs five-year follow-on contract with DoD valued at up to $171 mln​
September 25, 2017 / 11:40 AM / in a month

BRIEF-Emergent BioSolutions signs five-year follow-on contract with DoD valued at up to $171 mln​

Sept 25 (Reuters) - Emergent Biosolutions Inc

* Emergent BioSolutions to supply DoD with chemical threat countermeasure RSDL under five-year follow-on contract valued at up to $171 million

* Emergent BioSolutions Inc - ‍awarded a five-year follow-on contract valued at up to approximately $171 million by U.S. Department of defense​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below